Notch3 is overexpressed in HCC patients and positively correlated with clinicopathological parameters, including alpha-fetoprotein (AFP) levels, poor prognosis (shorter survival time), and cisplatin resistance. The gene discussed is AFP; the disease is hepatocellular carcinoma.